Evidence map›Paper›PMID 37478076›Full record

ArticlePloS one2023

Analysis of human invasive cytotrophoblasts demonstrates mosaic aneuploidy.

Jingly F Weier, Christy Ferlatte, Adolf Baumgartner, Ha Nam Nguyen, Beatrice A Weier, Heinz-Ulrich G Weier

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jingly F WeierDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California (U.C.), San Francisco, California, United States of America.ORCID 0000-0002-7617-7772
Christy FerlatteDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California (U.C.), San Francisco, California, United States of America.
Adolf BaumgartnerDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California (U.C.), San Francisco, California, United States of America.ORCID 0000-0001-7042-0308
Ha Nam NguyenDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California (U.C.), San Francisco, California, United States of America.
Beatrice A WeierGolden State Dermatology, Walnut Creek, California, United States of America.
Heinz-Ulrich G WeierLife Sciences Division, U.C. E.O. Lawrence Berkeley National Laboratory, Berkeley, California, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A total of 24 chromosome-specific fluorescence in situ hybridization probes for interphase nucleus analysis were developed to determine the chromosomal content of individual human invasive cytotrophoblasts derived from in vitro cultured assays. At least 75% of invasive cytotrophoblasts were hyperdiploid and the total number of chromosomes ranged from 47 to 61. The results also demonstrated that these hyperdiploid invasive cytotrophoblasts showed significant heterogeneity. The most copy number gains were observed for chromosomes 13, 14, 15, 19, 21, and 22 with average copy number greater than 2.3. A parallel study using primary invasive cytotrophoblasts also showed a similar trend of copy number changes. Conclusively, 24-chromosome analysis of human non-proliferating cytotrophoblasts (interphase nuclei) was achieved. Hyperdiploidy and chromosomal heterogeneity without endoduplication in invasive cytotrophoblasts may suggest a selective advantage for invasion and short lifespan during normal placental development.

Indexed as

PlacentaTrophoblastsAneuploidyCell NucleusFemaleHumansIn Situ Hybridization, FluorescenceInterphasePregnancy

Identifiers

PMID37478076
PMCPMC10361533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.